首页 > 市场调查报告书 > 医疗设备

手术用器具

市场调查报告书

商品编码

1566199

果冻市场规模、份额、成长分析、按产品、按应用、按最终用户、按地区 - 行业预测，2024-2031 年

Biosurgery Market Size, Share, Growth Analysis, By Product (Bone-Graft Substitutes, Soft-Tissue Attachments), By Application (General Surgery, Gynecological Surgery), By End User (Hospitals, Clinics), By Region - Industry Forecast 2024-2031

出版日期: 2024年10月03日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2022年果冻市场规模为145.6亿美元，从2023年的155.6亿美元成长到2031年的265.4亿美元，预计复合年增长率为6.9%。

由于手术方法的进步和对微创手术的日益偏好，全球果冻市场正在经历显着成长。果冻包括使用止血剂、密封剂和软组织修復产品等生物材料来帮助促进癒合过程并改善手术结果。有几个因素促进了这个市场的扩张，包括手术数量的增加、慢性病盛行率的上升以及老年人口的增加。此外，个人化医疗的趋势和创新生物製药的市场开拓在加速市场成长方面发挥着重要作用。然而，市场面临挑战，因为严格的监管标准和与果冻产品相关的高成本可能会阻碍更广泛的采用。儘管存在这些障碍，全球果冻市场为专注于创造和商业化先进外科技术的公司提供了巨大的商机。

市场概况
骨移植替代物
- 去矿物质骨基质
- 人工骨移植
- 骨形成蛋白
- 其他骨移植替代品
软组织附着
- 合成网
- 生物网
- 同种异体移植
- 异种移植
止血剂
- 凝血酶止血剂
- 氧化再生纤维素止血剂
- 复方止血剂
手术密封剂和黏剂
- 天然/生物来源密封剂和黏剂
- 按类型
- 纤维蛋白基密封剂和黏剂
- 胶原蛋白密封剂和黏剂
- 明胶基密封剂和黏剂
- 白蛋白基密封剂
- 其他天然/生物来源密封剂和黏剂
- 按产地
- 动物性密封剂和黏剂
- 基于人血的密封剂和黏剂
- 合成和半合成密封剂和黏剂
- 基于 PEG 水凝胶的密封剂和黏剂
- 氰基丙烯酸酯密封剂和黏剂
- 胺甲酸乙酯密封剂和黏剂
- 其他合成和半合成密封剂和黏剂
防沾黏屏障
- 合成防黏材料
- 玻尿酸类防沾黏材料
- 再生纤维素系防沾黏材料
- 钉类防黏材料
- 其他合成防沾剂
- 天然防沾屏障
- 胶原蛋白和蛋白质黏附屏障
- 纤维蛋白基防沾黏材料
钉线加固

果冻市场：依应用分类

市场概况
整形外科手术
一般外科
神经外科
心血管外科
重组手术
妇科手术
泌尿系统
胸腔外科
其他用途

果冻市场：依最终用户分类

市场概况
医院
诊所
其他最终用户

果冻市场规模：按地区划分

市场概况
北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲国家地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲 (MEA)
- 海湾合作委员会国家
- 南非
- 其他中东/非洲地区

竞争格局

前5名企业对比
主要企业市场定位（2023年）
主要市场参与者所采取的策略
近期市集活动
主要企业市场占有率（2023年）

主要企业简介

Baxter International Inc.（US）
B. Braun Melsungen AG（Germany）
Becton, Dickinson & Company（US）
Johnson & Johnson（US）
Medtronic Plc（Ireland）
Integra Lifesciences Holdings Corporation（US）
Commonwealth Serum Laboratories Limited（Australia）
Hemostasis LLC（US）
Pfizer Inc.（US）
Stryker Corporation（US）
Zimmer Biomet（US）
Kuros Biosciences AG（Switzerland）
Orthofix Medical Inc.（US）
Smith & Nephew Plc（UK）
Tissue Regenix Group Plc（UK）
Betatech Medical（Turkey）
Meril Life Sciences Pvt. Ltd.（India）
Samyang Holdings Corporation（South Korea）
Aroa Biosurgery Ltd.（New Zealand）
Meyer-Haake Gmbh（Germany）
Biom Up（France）
Biocer Entwicklungs-Gmbh（Germany）
Hannox International Corp.（Taiwan）

简介目录

Product Code: SQMIG35G2174

Biosurgery Market size was valued at USD 14.56 billion in 2022 and is poised to grow from USD 15.56 billion in 2023 to USD 26.54 billion by 2031, growing at a CAGR of 6.9% in the forecast period (2024-2031).

The global biosurgery market is undergoing notable growth, driven by advancements in surgical methods and the rising preference for minimally invasive procedures. Biosurgery encompasses the use of biological materials like hemostatic agents, sealants, and soft tissue repair products, which aid in enhancing the healing process and improving surgical results. Several factors are contributing to the expansion of this market, including the increasing number of surgeries, the rising incidence of chronic diseases, and the growing elderly population. Additionally, the trend toward personalized medicine and the development of innovative biologic products are playing a key role in accelerating market growth. However, the market faces challenges due to stringent regulatory standards and the high costs associated with biosurgery products, which may hinder wider adoption. Despite these obstacles, the global biosurgery market offers significant opportunities for companies focused on creating and commercializing advanced surgical technologies.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Biosurgery market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Biosurgery Market Segmental Analysis

Global Biosurgery Market is segmented by Product, Application, End User, end user and region. Based on Product, the market is segmented into Bone-Graft Substitutes, Soft-Tissue Attachments, Hemostatic Agents, Surgical Sealants & Adhesives, Adhesion Barriers, Staple-Line and Reinforcement Agents. Based on Application, the market is segmented into Orthopedic Surgery, General Surgery, Neurological Surgery, Cardiovascular Surgery, Reconstructive Surgery, Gynecological Surgery, Urological Surgery, Thoracic Surgery, and Other Applications. Based on End User, the market is segmented into Hospitals, Clinics, and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Drivers of the Global Biosurgery Market

A major factor fueling the growth of the global biosurgery market is the rising demand for minimally invasive surgical procedures. These products are commonly used in such surgeries due to their ability to reduce trauma, speed up recovery, and minimize scarring. As patients and surgeons increasingly favor less invasive techniques, the demand for biosurgery solutions continues to rise. Moreover, technological advancements, including the development of cutting-edge biomaterials and surgical sealants, are accelerating the market's expansion. These innovations are enhancing the effectiveness of biosurgery products, further boosting their adoption in various surgical applications.

Restraints in the Global Biosurgery Market

A significant challenge for the global biosurgery market is the strict regulatory requirements and prolonged approval processes for new products. Biosurgery products must undergo extensive testing, clinical trials, and meet stringent safety and efficacy standards. These regulatory demands can lead to delays in bringing new products to market and inflate development costs. Additionally, the complex regulatory environment can hinder manufacturers' ability to innovate and launch new offerings. The high costs of regulatory compliance and product development often create entry barriers, particularly for small and medium-sized companies, limiting their participation and slowing overall market growth.

Market Trends of the Global Biosurgery Market

A notable trend in the global biosurgery market is the increasing adoption of minimally invasive surgical procedures. These techniques provide multiple benefits compared to traditional open surgeries, such as smaller incisions, less scarring, quicker recovery, and fewer postoperative complications. Consequently, there is growing demand for biosurgical products tailored specifically for minimally invasive procedures. This trend is fueled by the rising preference among patients and healthcare providers for less invasive treatments that deliver comparable or improved outcomes. In response, manufacturers in the biosurgery market are focusing on developing innovative products and techniques to meet this demand and improve patient satisfaction.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factor
Degree of Competition
Top Investment Pockets
Ecosystem of the Market
Regulatory Analysis
Supply Chain Analysis

Biosurgery Market by Product

Market Overview
Bone-Graft Substitutes
- Demineralized Bone Matrix
- Synthetic Bone Grafts
- Bone Morphogenetic Proteins
- Other Bone-Graft Substitutes
Soft-Tissue Attachments
- Synthetic Meshes
- Biological Meshes
- Allografts
- Xenografts
Hemostatic Agents
- Thrombin-Based Hemostatic Agents
- Oxidized Regenerated Cellulose-Based Hemostatic Agents
- Combination Hemostatic Agents
Surgical Sealants & Adhesives
- Natural/Biological Sealants & Adhesives
- By Type
- Fibrin-Based Sealants & Adhesives
- Collagen-Based Sealants & Adhesives
- Gelatin-Based Sealants & Adhesives
- Albumin-Based Sealants
- Other Natural/Biological Sealants & Adhesives
- By Origin
- Animal-Based Sealants & Adhesives
- Human Blood-Based Sealants & Adhesives
- Synthetic And Semi-Synthetic Sealants & Adhesives
- PEG Hydrogel-Based Sealants & Adhesives
- Cyanoacrylate-Based Sealants & Adhesives
- Urethane-Based Sealants & Adhesives
- Other Synthetic And Semi-Synthetic Sealants & Adhesives
Adhesion Barriers
- Synthetic Adhesion Barriers
- Hyaluronic Acid-Based Adhesion Barriers
- Regenerated Cellulose-Based Adhesion Barriers
- Peg-Based Adhesion Barriers
- Other Synthetic Adhesion Barriers
- Natural Adhesion Barriers
- Collagen And Protein Adhesion Barriers
- Fibrin-Based Adhesion Barriers
Staple-Line Reinforcement Agents

Biosurgery Market by Application

Market Overview
Orthopedic Surgery
General Surgery
Neurological Surgery
Cardiovascular Surgery
Reconstructive Surgery
Gynecological Surgery
Urological Surgery
Thoracic Surgery
Other Applications

Biosurgery Market by End User

Market Overview
Hospitals
Clinics
Other End Users

Biosurgery Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Baxter International Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
B. Braun Melsungen AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson & Company (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic Plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Integra Lifesciences Holdings Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Commonwealth Serum Laboratories Limited (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hemostasis LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pfizer Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stryker Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Zimmer Biomet (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Kuros Biosciences AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Orthofix Medical Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Smith & Nephew Plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Tissue Regenix Group Plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Betatech Medical (Turkey)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Meril Life Sciences Pvt. Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Samyang Holdings Corporation (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Aroa Biosurgery Ltd. (New Zealand)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Meyer-Haake Gmbh (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biom Up (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biocer Entwicklungs-Gmbh (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hannox International Corp. (Taiwan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments